Aurobindo Pharma faces setback as US FDA issues 10 …
WEB2 days ago — Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) has completed its inspection at Unit II of Apitoria Pharma Private Limited, a wholly-owned subsidiary of Aurobindo, located in Telangana. The inspection, which was conducted from September 23 to 27, 2024, concluded with 10 …
Aurobindo Pharma subsidiary gets 10 observations from USFDA …
WEB2 days ago — Aurobindo Pharma on Monday said the US health regulator has issued 10 observations after inspecting the API facility of its subsidiary in Telangana. The US Food and Drug Administration (USFDA) inspected Unit-II, an active pharmaceutical ingredients (API) manufacturing facility of Apitoria Pharma, a ...
Aurobindo Pharma share down 4% as arm gets 10 observations …
WEB2 days ago — Aurobindo Pharma share declined 4.3 per cent today, logging an intraday low of Rs 1,443.5 per share on the BSE. The scrip dropped after the US Food and Drugs Administration (USFDA) inspected Apitoria Pharma, a subsidiary of Aurobindo Pharma's Active Pharmaceutical Ingredient (API) manufacturing facility in Telangana.
Aurobindo Pharma receives USFDA approval for Cephalexin Tablets
WEB1 day ago — Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP, 250 mg and 500 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Keflet Tablets, 250 mg and 500 mg, of Eli Lilly and Company.
Aurobindo Pharma News - Aurobindo Pharma Announcement, Latest News …
WEB2 days ago — Aurobindo to acquire 49% stake in GLS Pharma for Rs 22.5 crore. | News. 18 Sep, 2024, 04:27PM IST. Aurobindo Pharma Ltd on Wednesday said it will acquire the balance 49 per cent stake in GLS Pharma Ltd for Rs 22.5 crore to make the latter a wholly-owned subsidiary.
FDA classifies Aurobindo plant as needing 'voluntary' action
WEBDec 20, 2023 — The FDA has issued its final inspection report for an Aurobindo plant in India after a September inspection and a subsequent Form 483. The agency classified the plant as needing "voluntary"...
Aurobindo Pharma Outperforms Expectations with Strong Q4, …
WEBMay 27, 2024 — Aurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while...
Aurobindo Pharma Q1 Net profit jumps 61% on strong margins; …
WEBAug 11, 2024 — Aurobindo Pharma said its consolidated net profit increased 61 per cent year on year to Rs 919 crore in Q1FY25, aided by strong sales across markets, compared to Rs 571 crore in Q1FY24.
News Archives - Aurobindo Pharma USA
WEBAll News. February 09, 2024. Aurobindo Receives FDA Approval for Deflazacort Tablets 6mg, 18mg, 30mg, & 36mg. East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Deflazacort Tablets, 6mg, 18mg, 30mg, & 36mg.
India's Aurobindo Pharma posts jump in profit on strong …
WEBNov 9, 2023 — India's Aurobindo Pharma Ltd reported a better-than-expected 84.9% rise in second-quarter profit on Thursday, driven by strong sales in core markets Europe and the United States amid stablising...